Tech Company Financing Transactions
Bigfoot Biomedical Funding Round
Bigfoot Biomedical secured a $10 million Series C financing round on 6/4/2020. Investors included Abbott Laboratories, Cormorant Asset Management and Janus Henderson Investors.
Transaction Overview
Company Name
Announced On
6/4/2020
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to complete product development and FDA submission and clearance for the Bigfoot Unity System, part of the Bigfoot Unity Diabetes Management Program, a real-time, dose-decision support system for people with insulin-requiring diabetes relying on Multiple Daily Injection therapy, the most common form of insulin therapy for people with Type 1 and Type 2 diabetes.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1820 McCarthy Blvd.
Milpitas, CA 95035
USA
Milpitas, CA 95035
USA
Phone
Website
Email Address
Overview
We relentlessly strive to free people with insulin-requiring diabetes to live the lives they choose. By employing data-driven intelligence across an integrated device ecosystem, we are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/4/2020: Lili venture capital transaction
Next: 6/4/2020: Pairin venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs